Business Wire

ASCOM

Del
Finsk hospital bliver det første i verden, der indfører Ascom Myco-smartphones

Kuopio University Hospital (KUH) i Finland har som de første taget Ascom Myco, en smartphone som er specialudviklet til hospitals- og sundhedssektoren, i brug på deres neonatalafdeling.

“Det er selvfølgelig en fantastisk nyhed, at KUH er det første hospital i verden, der anvender Ascom Myco”, siger Ari-Pekka Tenko, som er salgs- og marketingdirektør hos Ascom Finland. “Det er dog endnu mere tilfredsstillende at se Ascom Myco blive anvendt på en så krævende og vigtig afdeling som neonatalafdelingen.”

KUH’s interesse i Ascom Myco-smartphonen var en følge af hospitalets implementering af en ny plejemodel. Modellen indebærer, at nyfødte bliver plejet i private familierum, så forældrene kan overnatte på hospitalet sammen med deres spædbarn. Forskning viser, at et sådant miljø kan forbedre udsigterne for neonatale børn og forkorte deres hospitalsophold.

"Familierums-modellen gør det muligt for mødrene at være sammen med deres barn. Mor og barn bliver aldrig adskilt, heller ikke hvis en af dem skulle blive syg", fortæller sygeplejerske Mila Hilden, som er projektleder på KHU’s neonatalafdeling.

Den nye model førte dog til længere svartider på patientalarmer. Eftersom de nyfødte var spredt over flere private stuer, var sygeplejerskerne nødt til at gå længere for at tjekke hver alarm på en monitor. “Det problem var vanskeligt at løse”, siger Juhani Kouri, som er projektleder hos KHU. “Vi kunne ikke have støjende alarmer på hele afdelingen, eftersom neonatale børn er særligt følsomme over for lydindtryk. Man kan opnå signifikante fordele ved at udelukke denne type forstyrrelser, da det kan være med til at forhindre livslang sygdom hos barnet. Derfor havde vi brug for en smartere måde at håndtere alarmer og patientkald på, hvis vi skulle bibeholde den nye familierums-model”.

Løsningen var Ascom Myco. Disse smartphones er, sammen med Ascom Unite Assign (en SW-løsning, der tildeler opgaver til personalet), nu koblet til hospitalets patientovervågningsudstyr og patientkaldesystem og bidrager dermed til en mere sikker og effektiv pleje af mødre og nyfødte.

“Alle alarmer fra patientovervågningen sendes nu til den relevante sygeplejerskes Ascom Myco-smartphone,” fortæller Tenko. “Sygeplejersken kan se, hvilken type alarm der er tale om, alarmens prioritet, og hvilken patient det drejer sig om. Hvis sygeplejersken ikke kan reagere på alarmen, videresendes den til en backup-sygeplejerske. Ascom Myco mindsker risikoen for, at en alarm bliver ignoreret, eftersom notifikationerne ikke automatisk sendes til alle sygeplejersker, men kun til dem, der har ansvaret for et bestemt barn”.

ABOUT ASCOM WIRELESS SOLUTIONS

Ascom Wireless Solutions (www.ascom.com/ws ) er en førende leverandør af innovative kommunikationsløsninger, som skaber integrerede og intelligente arbejdsgange på hospitaler, plejehjem og plejeboliger samt andre forretningsområder, hvor tidskritisk kommunikation spiller en afgørende rolle. Der er installeret cirka 100.000 systemer på verdensplan. Virksomheden tilbyder et bredt udvalg af talebaserede løsninger og professionelle meddelelsesløsninger, som skaber værdi for kunderne ved at optimere deres tidskritiske processer. Løsningerne er baseret på mobil-, VoWiFi- , IP-DECT- , patientkalde- og personsøger teknologier, som via Ascom Unite enkelt kan integreres i eksisterende virksomhedssystemer. Virksomheden har datterselskaber i 13 lande og har 1.200 medarbejdere på verdensplan. Ascom Wireless Solutions blev grundlagt i Göteborg i 1955 og er en del af Ascom Group, som er børsnoteret i Schweiz (ASCN:SIX).

Contact:

Læs mere om Ascom Myco på www.ascommyco.com/dk.eller kontakt:
Ascom Finland
Ari-Pekka Tenko, Director Sales & Marketing
Phone: +358 40 500 9904
Email: ari-pekka.tenko@ascom.com
eller
KYS:
Mila Hilden
+358 40 480 8889
mila.hilden@kuh.fi
eller
Juhani Kouri
+358 44 717 5871
juhani.kouri@kuh.fi

Link:

ClickThru

Information om Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Følg pressemeddelelser fra Business Wire

Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.

Flere pressemeddelelser fra Business Wire

Rimini Street Announces Upcoming 2025 Investor Conference Schedule15.5.2025 22:51:00 CEST | Press release

Rimini Street, Inc. (Nasdaq: RMNI), a global provider of end-to-end enterprise software support and innovation solutions, and the leading third-party support provider for Oracle, SAP and VMware software, today announced that Michael L. Perica, chief financial officer, and Dean Pohl, vice president, treasurer and investor relations, will be presenting and meeting with investors one-on-one and in small group meetings at the following conferences: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250515374696/en/ Rimini Street Announces Upcoming 2025 Investor Conference Schedule May 28, 2025: Craig-Hallum 22nd Annual Institutional Investor Conference, Minneapolis May 29, 2025: TD Cowen 53rd Annual TMT Conference, New York City Fireside Chat: 1:15 pm Eastern, webcast link June 24-26, 2025: Roth 15th Annual London Conference, London To schedule a meeting please contact your salesperson or Rimini Street Investor Relations at IR@rimin

Incyte Announces FDA Approval of Zynyz® (retifanlimab-dlwr) Making it the First and Only Approved First-Line Treatment for Advanced Anal Cancer Patients in the United States15.5.2025 20:30:00 CEST | Press release

Zynyz® (retifanlimab-dlwr), a PD-1 inhibitor, is now approved for the treatment of advanced squamous cell carcinoma of the anal canal (SCAC) in combination with chemotherapy and as a monotherapyPatients with SCAC treated with Zynyz achieved a statistically significant improvement in progression-free survival and improvement in overall survival Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Zynyz® (retifanlimab-dlwr), a humanized monoclonal antibody targeting programmed death receptor-1 (PD-1), in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with inoperable locally recurrent or metastatic squamous cell carcinoma of the anal canal (SCAC). In addition, the FDA granted approval for Zynyz as a single agent for the treatment of adult patients with locally recurrent or with metastatic SCAC with disease progression on or intolerance to platinum-based chemotherapy. Thi

DDC Announces Record 2024 Growth and Strategic Bitcoin Reserve Initiative in Shareholder Letter by Founder & CEO Norma Chu15.5.2025 20:23:00 CEST | Press release

DDC Enterprise Ltd. (NYSEAM: DDC), today released its 2024 full year results alongside a Shareholder Letter from Founder, Chairwoman, and CEO Norma Chu, underscoring the company’s positive financial performance and unveiling a pioneering Bitcoin accumulation strategy poised to redefine long-term value creation. To Our Valued Shareholders, 2024 was a year of transformative growth and strategic milestones for DDC. I am thrilled to share that we not only met our financial forecasts but exceeded expectations, delivering strong performance across key metrics while laying the groundwork for an even more exciting future. As we enter 2025, our momentum is accelerating, driven by disciplined execution and a bold new chapter in our corporate strategy. 2024 Financial & Operational HighlightsRevenue Growth: USD 37.4 million, a 33% year-over-year increase, propelled by the strategic acquisition of U.S. brands and sustained resilience in our core China operations. Margin Expansion: Gross profit marg

Ras Al Khaimah’s Strong Economic and Investment Environment Validated by Fitch Affirmation of ‘A+’ Credit Rating, With Stable Outlook15.5.2025 20:18:00 CEST | Press release

The positive rating reflects the Emirate’s strong long-term growth prospects and ongoing economic diversification Ras Al Khaimah’s strategic approach to sustainable, cross-sector growth and strong economic and investment environment has been validated by international credit rating agency Fitch, which reaffirmed the rating at ‘A+’ with a stable outlook. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250515907689/en/ Ras Al Khaimah’s strong economic and investment environment validated by Fitch affirmation of ‘A+’ credit rating, with Stable Outlook (Photo: AETOSWire) Ras Al Khaimah Government welcomed the announcement as an endorsement of the Emirate’s resilient and expanding economy, sound fiscal management and the clear vision and unwavering commitment of its leadership to sustainable, long-term development and growth. The Emirate’s landmark tourism projects, including a major integrated resort, luxury hotels and world-clas

Cessna Citation CJ4 Gen3 Flight Test Program Advances Through Milestones as Second Test Article Takes Flight15.5.2025 20:00:00 CEST | Press release

Textron Aviation today announced a major program milestone for the Cessna Citation CJ4 Gen3 flight test program with the successful first flight of a second test article — P1. Testing on the P1 aircraft will focus on avionics, human factors and interiors. The Citation CJ4 Gen3 business jet is designed to keep pilots a step ahead in the cockpit by offering the next-generation Garmin G3000 PRIME avionics along with the most standard features in its class. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250515438856/en/ Cessna Citation CJ4 Gen3 flight test program advances through milestones as second test article takes flight. (Photo Credit: Textron Aviation) The Cessna Citation CJ4 Gen3 is designed and manufactured by Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company. “This achievement continues the forward momentum of the CJ4 Gen3 program and reflects the dedication and expertise of our team in designing, certifying an

I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.

Besøg vores nyhedsrum
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye